Compare with prior probability (20%), the positive posttest probability (81%) is much higher and the negative posttest probability is quite lower (<0.1), indicating a high diagnostic potential of cfDNA in detecting KRAS status in CRC patients (Figure 4A). Here, KRAS is linked to colorectal carcinoma.